Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06100731 · ClinicalTrials.gov registry record · NA
tDCS and Inhibitory Control in PTSD
A NA study, sponsored by Gopalkumar Rakesh.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT06100731 is a NA study that has completed, run by Gopalkumar Rakesh. The registered enrollment target is 38 participants.
The verdict
NCT06100731, a NA study, has completed, sponsored by Gopalkumar Rakesh.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Large samples (\~2,000/yr) of adult undergraduate students at a large southern university will be pre-screened via the University of Kentucky SONA System (IRB#43626) to identify and recruit adult female participants who report a history of IPV and probable PTSD to participate in a one-day lab study. After completing an IRB-approved informed consent, participants will complete a brief psychiatric diagnostic interview and a battery of questionnaires. They will then complete three blocks of the Stop Signal Task (SST). Participants will be randomized (double-blind, stratified by PTSD diagnosis and psychotropic medication use) to receive 15-min of active or sham multifocal tDCS targeting the rIFG. tDCS will be delivered offline for 11.5-mins after block 1 of the SST and online for 3.5-mins during block 2 of the SST. Sham stimulation will be identical to active tDCS, but electrical current will only be ramped in/out at the beginning and end of the 15-mins. The third block of the SST will be completed after tDCS. Lastly, participants will complete a pictorial trauma-related symptom provocation task. Participants will be compensated with course credit.
Interventions
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2023-10-27 |
| Est. Completion | 2024-12-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06100731
The ClinicalTrials.gov registry entry for NCT06100731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gopalkumar Rakesh, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.
NCT06100731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06100731 about?
NCT06100731 is a clinical study titled "tDCS and Inhibitory Control in PTSD". Large samples (\~2,000/yr) of adult undergraduate students at a large southern university will be pre-screened via the University of Kentucky SONA System (IRB#43626) to identify and recruit adult female participants who report a history of IPV and probable PTSD to participate in a one-day lab study....
What is the current status of trial NCT06100731?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2023-10-27. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT06100731?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT06100731?
This trial is sponsored by Gopalkumar Rakesh, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.